EUCOPE News by Tag — Rare Disease

Filtered by Tag: Rare Disease

EUCOPE Resources / News / Press Releases - November 25, 2020

EC Pharmaceutical Strategy – Time for a Modern Approach to Value

EUCOPE, the European association for small to medium-sized companies active in pharmaceuticals and biotechnologies – many of which are researching and developing rare disease treatments – notes the publication of the European Commission Communication on the Pharmaceutical Strategy for Europe. EUCOPE calls for a comprehensive Pharmaceutical Strategy… read more

Events & Meetings / News - October 30, 2020

JOIN US: Case studies on rare disease therapies development – A laboratory of ideas for European innovation leadership

Pharmaceutical small to mid-sized companies and start-ups constitute a laboratory of innovation and should be nurtured through a forward-looking European incentives ecosystem that encourages the development of cutting-edge technologies. The upcoming EU health policy initiatives, including the Pharmaceutical Strategy for Europe and the impact assessment… read more

News - October 28, 2020

Sickle Cell Disease: An European Overview

Sickle cell disease is one of the most prevalent genetic diseases in Europe. A recent report, commissioned by our member company Global Blood Therapeutics, use the latest data from 5 EU countries to draw recommendations to improve the life expectancy of people living with this… read more